HALO logo
halo search icon
Trinity Biotech Plc Sponsored ADR Class A
Trinity Biotech Plc Sponsored ADR Class A
TRIB · NAS

Trinity Biotech Plc Sponsored ADR Class A

US$0.60

Price Arrow0.039 (6.96%)
20/05/2026 04:00:00 PM
Big CandleEngulfing BullishHammer Bearish
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Trinity Biotech Plc Sponsored ADR Class A Overview

TRIB Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About TRIB

icon

Telephone

353.1.276.9800

icon

Address

IDA Business Park, Bray, Wicklow 10

Description

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

TRIB Price Chart

Key Stats

Market Cap

US$10.58M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.5 - 17.2

Trade Value (12mth)

US$795,403.00

1 week

-1.62%

1 month

-18.92%

YTD

-24.27%

1 year

-85.44%

All time high

701.50

Key Fundamentals

EPS 3 yr Growth

-66.80%

EBITDA Margin

-18.80%

Operating Cashflow

-$6m

Free Cash Flow Return

-68.50%

ROIC

-410.30%

Interest Coverage

-0.40

Quick Ratio

0.10

Other Data

Shares Outstanding (Fully Diluted)

19m

HALO Sector

Healthcare

Next Company Report Date

25-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

TRIB Announcements

Latest Announcements

DateAnnouncements
14 May 26
14 May 26
14 May 26
14 May 26
14 May 26

TRIB Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-3.14-1.77-2.02locklocklock
EPS (Fully Diluted)
$locklocklocklock-3.14-1.77-2.02locklocklock
Growth
%locklocklocklock48.343.8-14.2locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Trinity Biotech Plc Sponsored ADR Class A (TRIB:NAS)?
Halo FAQ
The current share price of Trinity Biotech Plc Sponsored ADR Class A (TRIB:NAS) is USD$0.60.
What is the 52-week high share price for Trinity Biotech Plc Sponsored ADR Class A (TRIB:NAS)?
Halo FAQ
The 52-week high share price for Trinity Biotech Plc Sponsored ADR Class A (TRIB:NAS) is USD$17.20.
What is the 52-week low share price for Trinity Biotech Plc Sponsored ADR Class A (TRIB:NAS)?
Halo FAQ
The 52-week low share price for Trinity Biotech Plc Sponsored ADR Class A (TRIB:NAS) is USD$0.50.
What is the dividend yield for Trinity Biotech Plc Sponsored ADR Class A (TRIB:NAS)?
Halo FAQ
Trinity Biotech Plc Sponsored ADR Class A (TRIB:NAS) does not pay a dividend.
What was Trinity Biotech Plc Sponsored ADR Class A (TRIB:NAS) last dividend payment?
Halo FAQ
The last dividend payment of Trinity Biotech Plc Sponsored ADR Class A (TRIB:NAS) is USD$0.22.
What is the franking level for Trinity Biotech Plc Sponsored ADR Class A (TRIB:NAS)?
Halo FAQ
Trinity Biotech Plc Sponsored ADR Class A (TRIB:NAS) has a franking level of 0.00%.
In which sector is Trinity Biotech Plc Sponsored ADR Class A (TRIB:NAS) classified?
Halo FAQ
Trinity Biotech Plc Sponsored ADR Class A (TRIB:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.